15.2M XNYS Volume
XNYS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Jannie Oosthuizen | President, U.S. Market | Sale of securities on an exchange or to another person at price $ 84.09 per share. | 19 Feb 2025 | 8,500 | 30,705 (0%) | 0% | 84.1 | 714,745 | Common Stock |
| David Michael Williams | EVP,Chief Info&Digital Officer | Sale of securities on an exchange or to another person at price $ 85.34 per share. | 13 Feb 2025 | 6,000 | 24,123 (0%) | 0% | 85.3 | 512,057 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 13,002 | 0 | - | - | Restricted Stock Unit | |
| Jannie Oosthuizen | President, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.28 per share. | 08 Feb 2025 | 6,404 | 39,205 (0%) | 0% | 87.3 | 558,941 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.28 per share. | 08 Feb 2025 | 13,002 | 45,609 (0%) | 0% | 87.3 | 1,134,815 | Common Stock |
| Inge G. Thulin | Director | Purchase of securities on an exchange or from another person at price $ 88.28 per share. | 06 Feb 2025 | 2,832 | 2,932 (0%) | 0% | 88.3 | 250,000 | Common Stock |
| Cristal N. Downing | Chief Comm. & Public Afrs Ofcr | Sale of securities on an exchange or to another person at price $ 88.76 per share. | 06 Feb 2025 | 2,361 | 7,085 (0%) | 0% | 88.8 | 209,551 | Common Stock |
| Douglas M. Baker | Director | Purchase of securities on an exchange or from another person at price $ 88.50 per share. | 05 Feb 2025 | 15,000 | 16,000 (0%) | 0% | 88.5 | 1,327,500 | Common Stock |
| Caroline A. Litchfield | EVP & CFO | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 23,432 | 74,340 (0%) | 0% | 97.9 | 2,294,930 | Common Stock |
| David Michael Williams | EVP,Chief Info&Digital Officer | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 10,246 | 30,123 (0%) | 0% | 97.9 | 1,003,493 | Common Stock |
| Dean Y. Li | Executive VP & President, MRL | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 32,621 | 79,592 (0%) | 0% | 97.9 | 3,194,901 | Common Stock |
| Cristal N. Downing | Chief Comm. & Public Afrs Ofcr | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 9,446 | 9,446 (0%) | 0% | 97.9 | 925,141 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 8,664 | 32,607 (0%) | 0% | 97.9 | 848,552 | Common Stock |
| Dalton E. Smart | SVP Fin. - Global Controller | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 2,586 | 7,014 (0%) | 0% | 97.9 | 253,273 | Common Stock |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 25,438 | 178,992 (0%) | 0% | 97.9 | 2,491,398 | Common Stock |
| Robert M. Davis | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 95,275 | 443,601 (0%) | 0% | 97.9 | 9,331,234 | Common Stock |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 28,136 | 78,758 (0%) | 0% | 97.9 | 2,755,640 | Common Stock |
| Chirfi Guindo | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 28,158 | 69,143 (0%) | 0% | 97.9 | 2,757,795 | Common Stock |
| Jennifer Zachary | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 25,423 | 55,285 (0%) | 0% | 97.9 | 2,489,929 | Common Stock |
| Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 429 | 97,074 | - | - | Phantom Stock | |
| Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 264 | 23,574 | - | - | Phantom Stock | |
| Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 71 | 14,977 | - | - | Phantom Stock | |
| Chirfi Guindo | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 115.20 per share. | 05 Aug 2024 | 36,901 | 57,781 (0%) | 0% | 115.2 | 4,250,995 | Common Stock |
| Chirfi Guindo | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2024 | 36,901 | 36,903 | - | - | Restricted Stock Unit | |
| Chirfi Guindo | Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.20 per share. | 05 Aug 2024 | 17,412 | 40,369 (0%) | 0% | 115.2 | 2,005,862 | Common Stock |
| Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 393 | 96,063 | - | - | Phantom Stock | |
| Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 242 | 23,169 | - | - | Phantom Stock | |
| Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 65 | 14,815 | - | - | Phantom Stock | |
| Douglas M. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 6,281 | - | - | Phantom Stock | |
| Inge G. Thulin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 21,228 | - | - | Phantom Stock | |
| Patricia F. Russo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 53,951 | - | - | Phantom Stock | |
| Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 95,669 | - | - | Phantom Stock | |
| Pamela J. Craig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 28,233 | - | - | Phantom Stock | |
| Risa J. Lavizzo-Mourey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 12,120 | - | - | Phantom Stock | |
| Kathy J. Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 12,252 | - | - | Phantom Stock | |
| Paul B. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 28,233 | - | - | Phantom Stock | |
| Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 22,927 | - | - | Phantom Stock | |
| Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 14,749 | - | - | Phantom Stock | |
| Stephen L. Mayo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 9,379 | - | - | Phantom Stock | |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.51 per share. | 04 May 2024 | 13,360 | 150,359 (0%) | 0% | 127.5 | 1,703,534 | Common Stock |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Exercise or conversion of derivative security received from the company (such as an option) at price $ 127.51 per share. | 04 May 2024 | 27,126 | 163,719 (0%) | 0% | 127.5 | 3,458,836 | Common Stock |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 27,126 | 0 | - | - | Restricted Stock Unit | |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.51 per share. | 04 May 2024 | 437 | 23,621 (0%) | 0% | 127.5 | 55,722 | Common Stock |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 127.51 per share. | 04 May 2024 | 887 | 24,058 (0%) | 0% | 127.5 | 113,101 | Common Stock |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 887 | 0 | - | - | Restricted Stock Unit | |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 912 | 0 | - | - | Restricted Stock Unit | |
| Jannie Oosthuizen | President, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.51 per share. | 04 May 2024 | 450 | 23,820 (0%) | 0% | 127.5 | 57,380 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 127.51 per share. | 04 May 2024 | 912 | 24,270 (0%) | 0% | 127.5 | 116,289 | Common Stock |
| Dalton E. Smart | SVP Fin. - Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 128.26 per share. | 03 May 2024 | 516 | 3,433 (0%) | 0% | 128.3 | 66,182 | Common Stock |
| Dalton E. Smart | SVP Fin. - Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 612 | 0 | - | - | Restricted Stock Unit | |
| Dalton E. Smart | SVP Fin. - Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 1,530 | 1,532 | - | - | Restricted Stock Unit | |
| Dalton E. Smart | SVP Fin. - Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 516 | 518 | - | - | Restricted Stock Unit | |
| Dalton E. Smart | SVP Fin. - Global Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.51 per share. | 03 May 2024 | 302 | 4,428 (0%) | 0% | 127.5 | 38,508 | Common Stock |
| Dalton E. Smart | SVP Fin. - Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 127.51 per share. | 03 May 2024 | 612 | 4,730 (0%) | 0% | 127.5 | 78,036 | Common Stock |
| Dalton E. Smart | SVP Fin. - Global Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.26 per share. | 03 May 2024 | 590 | 4,118 (0%) | 0% | 128.3 | 75,673 | Common Stock |
| Dalton E. Smart | SVP Fin. - Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 128.26 per share. | 03 May 2024 | 1,530 | 4,708 (0%) | 0% | 128.3 | 196,238 | Common Stock |
| Dalton E. Smart | SVP Fin. - Global Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.26 per share. | 03 May 2024 | 255 | 3,178 (0%) | 0% | 128.3 | 32,706 | Common Stock |
| David Michael Williams | EVP,Chief Info&Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 16,406 | 16,406 | - | - | Stock Option (Right to Buy) | |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 23,216 | 23,216 | - | - | Restricted Stock Unit | |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Robert M. Davis | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 181,641 | 181,641 | - | - | Stock Option (Right to Buy) | |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 38,672 | 38,672 | - | - | Stock Option (Right to Buy) | |
| Chirfi Guindo | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 29,297 | 29,297 | - | - | Stock Option (Right to Buy) | |
| Jennifer Zachary | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 35,156 | 35,156 | - | - | Stock Option (Right to Buy) | |
| Caroline Litchfield | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 49,805 | 49,805 | - | - | Stock Option (Right to Buy) | |
| Dean Y. Li | Executive VP & President, MRL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 65,625 | 65,625 | - | - | Stock Option (Right to Buy) | |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 20,508 | 20,508 | - | - | Stock Option (Right to Buy) | |
| Cristal N. Downing | Chief Comm. & Public Afrs Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 15,234 | 15,234 | - | - | Stock Option (Right to Buy) | |
| Jannie Oosthuizen | President, U.S. Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 20,508 | 20,508 | - | - | Stock Option (Right to Buy) | |
| Joseph Romanelli | President, Human Health Int?l | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 6,191 | 6,191 | - | - | Restricted Stock Unit | |
| Joseph Romanelli | President, Human Health Int?l | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.80 per share. | 30 Apr 2024 | 1,115 | 20,716 (0%) | 0% | 128.8 | 143,612 | Common Stock |
| Joseph Romanelli | President, Human Health Int?l | Exercise or conversion of derivative security received from the company (such as an option) at price $ 128.80 per share. | 30 Apr 2024 | 2,262 | 21,831 (0%) | 0% | 128.8 | 291,346 | Common Stock |
| Joseph Romanelli | President, Human Health Int?l | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 23,438 | 23,438 | - | - | Stock Option (Right to Buy) | |
| Joseph Romanelli | President, Human Health Int?l | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 2,262 | 4,524 | - | - | Restricted Stock Unit | |
| Dalton E. Smart | SVP Fin. - Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 128.80 per share. | 30 Apr 2024 | 381 | 3,048 (0%) | 0% | 128.8 | 49,073 | Common Stock |
| Dalton E. Smart | SVP Fin. - Global Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.80 per share. | 30 Apr 2024 | 131 | 2,917 (0%) | 0% | 128.8 | 16,873 | Common Stock |
| Dalton E. Smart | SVP Fin. - Global Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 1,393 | 1,393 | - | - | Restricted Stock Unit | |
| Dalton E. Smart | SVP Fin. - Global Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 7,031 | 7,031 | - | - | Stock Option (Right to Buy) | |
| Dalton E. Smart | SVP Fin. - Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 381 | 764 | - | - | Restricted Stock Unit | |
| Betty D. Larson | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 34,050 | 34,050 | - | - | Restricted Stock Unit | |
| Betty D. Larson | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 58,594 | 58,594 | - | - | Stock Option (Right to Buy) | |
| Betty D. Larson | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 31,055 | 31,055 | - | - | Stock Option (Right to Buy) | |
| Peter C. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 227 | 124,752 | - | - | Phantom Stock | |
| Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 341 | 93,360 | - | - | Phantom Stock | |
| Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 227 | 21,049 | - | - | Phantom Stock | |
| Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 61 | 12,920 | - | - | Phantom Stock | |
| Litchfield Caroline | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.08 per share. | 14 Feb 2024 | 38,291 | 89,199 (0%) | 0% | 58.1 | 2,223,941 | Common Stock |
| Litchfield Caroline | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 38,291 | 0 | - | - | Stock Option (Right to Buy) | |
| Caroline Litchfield | EVP & CFO | Sale of securities on an exchange or to another person at price $ 125.50 per share. | 14 Feb 2024 | 38,291 | 50,908 (0%) | 0% | 125.5 | 4,805,521 | Common Stock |
| Joseph Romanelli | President, Human Health Int?l | Sale of securities on an exchange or to another person at price $ 124.89 per share. | 13 Feb 2024 | 1,000 | 19,569 (0%) | 0% | 124.9 | 124,888 | Common Stock |
| M. Davis Robert | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 108,491 | 181,781 | - | - | Stock Option (Right to Buy) | |
| M. Robert Davis | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 41,509 | 83,020 | - | - | Stock Option (Right to Buy) | |
| Robert Davis M. | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.36 per share. | 13 Feb 2024 | 41,509 | 389,835 (0%) | 0% | 75.4 | 3,128,118 | Common Stock |
| Robert M. Davis | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 85,021 | 96,760 | - | - | Stock Option (Right to Buy) | |
| Robert M. Davis | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 126.37 per share. | 13 Feb 2024 | 25,324 | 348,326 (0%) | 0% | 126.4 | 3,200,277 | Common Stock |
| Davis Robert M. | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 125.40 per share. | 13 Feb 2024 | 85,021 | 348,326 (0%) | 0% | 125.4 | 10,661,574 | Common Stock |
| Davis Robert M. | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 13 Feb 2024 | 108,491 | 498,326 (0%) | 0% | 73.7 | 7,999,041 | Common Stock |
| Robert Davis M. | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 125.74 per share. | 13 Feb 2024 | 124,676 | 373,650 (0%) | 0% | 125.7 | 15,677,147 | Common Stock |
| Robert M. Davis | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 13 Feb 2024 | 85,021 | 433,347 (0%) | 0% | 73.7 | 6,268,598 | Common Stock |
| Dean Li Y. | Executive VP & President, MRL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 14,702 | 0 | - | - | Stock Option (Right to Buy) | |
| Li Dean Y. | Executive VP & President, MRL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.07 per share. | 09 Feb 2024 | 14,702 | 60,944 (0%) | 0% | 62.1 | 912,553 | Common Stock |
| Y. Dean Li | Executive VP & President, MRL | Sale of securities on an exchange or to another person at price $ 125.50 per share. | 09 Feb 2024 | 14,702 | 46,242 (0%) | 0% | 125.5 | 1,845,083 | Common Stock |
| Williams David Michael | EVP,Chief Info&Digital Officer | Sale of securities on an exchange or to another person at price $ 127.57 per share. | 07 Feb 2024 | 1,451 | 19,811 (0%) | 0% | 127.6 | 185,108 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 7,045 | 7,049 | - | - | Stock Option (Right to Buy) | |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.36 per share. | 02 Feb 2024 | 6,773 | 28,122 (0%) | 0% | 75.4 | 510,413 | Common Stock |
| Steven Mizell C. | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 32,170 | 22,088 | - | - | Stock Option (Right to Buy) | |
| Zachary Jennifer | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.10 per share. | 02 Feb 2024 | 19,417 | 78,556 (0%) | 0% | 87.1 | 1,691,221 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Sale of securities on an exchange or to another person at price $ 127.18 per share. | 02 Feb 2024 | 18,959 | 23,327 (0%) | 0% | 127.2 | 2,411,111 | Common Stock |
| C. Steven Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 824 | 0 | - | - | Stock Option (Right to Buy) | |
| Mizell Steven C. | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 70.71 per share. | 02 Feb 2024 | 824 | 42,143 (0%) | 0% | 70.7 | 58,265 | Common Stock |
| Oosthuizen Jannie | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 02 Feb 2024 | 7,045 | 35,167 (0%) | 0% | 73.7 | 519,428 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 7,119 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Jennifer Zachary | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 126.97 per share. | 02 Feb 2024 | 49,499 | 29,057 (0%) | 0% | 127.0 | 6,284,779 | Common Stock |
| Zachary Jennifer | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 19,417 | 38,835 | - | - | Stock Option (Right to Buy) | |
| Mizell Steven C. | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 126.65 per share. | 02 Feb 2024 | 50,694 | 23,619 (0%) | 0% | 126.6 | 6,420,349 | Common Stock |
| C. Mizell Steven | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 02 Feb 2024 | 32,170 | 74,313 (0%) | 0% | 73.7 | 2,371,894 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 6,773 | 0 | - | - | Stock Option (Right to Buy) | |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.10 per share. | 02 Feb 2024 | 7,119 | 42,286 (0%) | 0% | 87.1 | 620,065 | Common Stock |
| Smart E. Dalton | SVP Fin. - Global Controller | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 2,661 | 2,667 (0%) | 0% | 119.4 | 317,803 | Common Stock |
| Klobuchar A Michael | EVP - Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 3,896 | 23,098 (0%) | 0% | 119.4 | 465,299 | Common Stock |
| M. Davis Robert | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 76,510 | 348,326 (0%) | 0% | 119.4 | 9,137,589 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 3,133 | 21,349 (0%) | 0% | 119.4 | 374,174 | Common Stock |
| Zachary Jennifer | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 23,298 | 59,139 (0%) | 0% | 119.4 | 2,782,480 | Common Stock |
| Chattopadhyay Sanat | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 26,716 | 26,716 (0%) | 0% | 119.4 | 3,190,692 | Common Stock |
| Litchfield Caroline | EVP & CFO | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 19,208 | 50,908 (0%) | 0% | 119.4 | 2,294,011 | Common Stock |
| David Michael Williams | EVP,Chief Info&Digital Officer | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 10,196 | 21,262 (0%) | 0% | 119.4 | 1,217,708 | Common Stock |
| Y. Dean Li | Executive VP & President, MRL | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 25,760 | 46,242 (0%) | 0% | 119.4 | 3,076,517 | Common Stock |
| Mizell C. Steven | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 18,384 | 41,319 (0%) | 0% | 119.4 | 2,195,601 | Common Stock |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 23,296 | 135,782 (0%) | 0% | 119.4 | 2,782,241 | Common Stock |
| Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 275 | 20,688 | - | - | Phantom Stock | |
| Christine Seidman E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 74 | 12,775 | - | - | Phantom Stock | |
| Peter C. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 275 | 123,715 | - | - | Phantom Stock | |
| Henry Glocer Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 412 | 92,419 | - | - | Phantom Stock | |
| Jannie Oosthuizen | President, U.S. Market | Sale of securities on an exchange or to another person at price $ 102.38 per share. | 09 Nov 2023 | 2,081 | 18,190 (0%) | 0% | 102.4 | 213,061 | Common Stock |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Sale of securities on an exchange or to another person at price $ 105.03 per share. | 08 Nov 2023 | 43,823 | 111,763 (0%) | 0% | 105.0 | 4,602,668 | Common Stock |
| Cristal N. Downing | Chief Comm. & Public Afrs Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2023 | 11,685 | 11,685 | - | - | Restricted Stock Unit | |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 102.82 per share. | 30 Oct 2023 | 915 | 20,722 (0%) | 0% | 102.8 | 94,080 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2023 | 915 | 0 | - | - | Restricted Stock Unit | |
| Jannie Oosthuizen | President, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.82 per share. | 30 Oct 2023 | 451 | 20,271 (0%) | 0% | 102.8 | 46,372 | Common Stock |
| Peter C. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 291 | 122,580 | - | - | Phantom Stock | |
| Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 437 | 91,370 | - | - | Phantom Stock | |
| Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 291 | 20,272 | - | - | Phantom Stock | |
| Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 78 | 12,612 | - | - | Phantom Stock | |
| Steven C. Mizell | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 109.01 per share. | 14 Aug 2023 | 4,250 | 22,935 (0%) | 0% | 109.0 | 463,293 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 105.49 per share. | 03 Aug 2023 | 4,500 | 27,185 (0%) | 0% | 105.5 | 474,701 | Common Stock |
| Chirfi Guindo | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 105.70 per share. | 03 Aug 2023 | 36,901 | 38,341 (0%) | 0% | 105.7 | 3,900,436 | Common Stock |
| Chirfi Guindo | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 36,901 | 73,804 | - | - | Restricted Stock Unit | |
| Chirfi Guindo | Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.70 per share. | 03 Aug 2023 | 17,989 | 20,352 (0%) | 0% | 105.7 | 1,901,437 | Common Stock |
| Joseph Romanelli | President, Human Health Int?l | Sale of securities on an exchange or to another person at price $ 107.37 per share. | 02 Aug 2023 | 59 | 0 (0%) | 0% | 107.4 | 6,335 | Common Stock |
| Joseph Romanelli | President, Human Health Int?l | Sale of securities on an exchange or to another person at price $ 107.37 per share. | 02 Aug 2023 | 30 | 20,569 (0%) | 0% | 107.4 | 3,221 | Common Stock |
| Peter C. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 259 | 121,484 | - | - | Phantom Stock | |
| Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 389 | 90,340 | - | - | Phantom Stock | |
| Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 259 | 19,851 | - | - | Phantom Stock | |
| Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 70 | 12,451 | - | - | Phantom Stock | |
| Douglas M. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 4,412 | - | - | Phantom Stock | |
| Inge G. Thulin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 18,973 | - | - | Phantom Stock | |
| Patricia F. Russo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 50,851 | - | - | Phantom Stock | |
| Peter C. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 121,224 | - | - | Phantom Stock | |
| Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 89,950 | - | - | Phantom Stock | |
| Pamela J. Craig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 25,797 | - | - | Phantom Stock | |
| Risa J. Lavizzo-Mourey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 10,100 | - | - | Phantom Stock | |
| Kathy J. Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 10,228 | - | - | Phantom Stock | |
| Paul B. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 25,797 | - | - | Phantom Stock | |
| Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 19,591 | - | - | Phantom Stock | |
| Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 12,381 | - | - | Phantom Stock | |
| Stephen L. Mayo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 7,430 | - | - | Phantom Stock | |
| Jennifer Zachary | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 117.59 per share. | 04 May 2023 | 19,141 | 35,127 (0%) | 0% | 117.6 | 2,250,834 | Common Stock |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.22 per share. | 04 May 2023 | 885 | 19,476 (0%) | 0% | 118.2 | 104,625 | Common Stock |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.22 per share. | 04 May 2023 | 436 | 19,040 (0%) | 0% | 118.2 | 51,544 | Common Stock |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2023 | 885 | 887 | - | - | Restricted Stock Unit | |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2023 | 907 | 912 | - | - | Restricted Stock Unit | |
| Jannie Oosthuizen | President, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.22 per share. | 04 May 2023 | 447 | 19,759 (0%) | 0% | 118.2 | 52,844 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.22 per share. | 04 May 2023 | 907 | 20,206 (0%) | 0% | 118.2 | 107,226 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.36 per share. | 03 May 2023 | 15,000 | 61,085 (0%) | 0% | 75.4 | 1,130,400 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.62 per share. | 03 May 2023 | 13,000 | 46,085 (0%) | 0% | 77.6 | 1,009,060 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2023 | 12,000 | 32,151 | - | - | Stock Option (Right to Buy) | |
| Steven C. Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2023 | 15,000 | 44,151 | - | - | Stock Option (Right to Buy) | |
| Steven C. Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2023 | 12,000 | 54,258 | - | - | Stock Option (Right to Buy) | |
| Steven C. Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2023 | 13,000 | 39,366 | - | - | Stock Option (Right to Buy) | |
| Steven C. Mizell | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 119.01 per share. | 03 May 2023 | 13,400 | 31,685 (0%) | 0% | 119.0 | 1,594,734 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.36 per share. | 03 May 2023 | 12,000 | 45,085 (0%) | 0% | 75.4 | 904,320 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 119.01 per share. | 03 May 2023 | 15,000 | 45,085 (0%) | 0% | 119.0 | 1,785,122 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 119.01 per share. | 03 May 2023 | 12,000 | 33,085 (0%) | 0% | 119.0 | 1,428,089 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 119.01 per share. | 03 May 2023 | 13,000 | 60,085 (0%) | 0% | 119.0 | 1,547,112 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 03 May 2023 | 12,000 | 73,085 (0%) | 0% | 73.7 | 884,760 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2023 | 949 | 951 | - | - | Restricted Stock Unit | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2023 | 15,875 | 0 | - | - | Stock Option (Right to Buy) | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2023 | 803 | 1,608 | - | - | Restricted Stock Unit | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Sale of securities on an exchange or to another person at price $ 117.53 per share. | 03 May 2023 | 15,875 | 45,709 (0%) | 0% | 117.5 | 1,865,843 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.07 per share. | 03 May 2023 | 15,875 | 61,584 (0%) | 0% | 62.1 | 985,361 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.22 per share. | 03 May 2023 | 326 | 45,709 (0%) | 0% | 118.2 | 38,540 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.22 per share. | 03 May 2023 | 949 | 46,035 (0%) | 0% | 118.2 | 112,191 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.89 per share. | 03 May 2023 | 276 | 45,086 (0%) | 0% | 117.9 | 32,538 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.89 per share. | 03 May 2023 | 803 | 45,362 (0%) | 0% | 117.9 | 94,666 | Common Stock |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.89 per share. | 03 May 2023 | 236 | 4,607 (0%) | 0% | 117.9 | 27,822 | Common Stock |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2023 | 813 | 816 | - | - | Restricted Stock Unit | |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2023 | 689 | 1,378 | - | - | Restricted Stock Unit | |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.22 per share. | 03 May 2023 | 279 | 5,141 (0%) | 0% | 118.2 | 32,983 | Common Stock |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.22 per share. | 03 May 2023 | 813 | 5,420 (0%) | 0% | 118.2 | 96,113 | Common Stock |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.89 per share. | 03 May 2023 | 689 | 4,843 (0%) | 0% | 117.9 | 81,226 | Common Stock |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 44,260 | 44,260 | - | - | Stock Option (Right to Buy) | |
| Robert M. Davis | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 186,722 | 186,722 | - | - | Stock Option (Right to Buy) | |
| Steven C. Mizell | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 29,046 | 29,046 | - | - | Stock Option (Right to Buy) | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 1,781 | 1,781 | - | - | Restricted Stock Unit | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 9,682 | 9,682 | - | - | Stock Option (Right to Buy) | |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 45,643 | 45,643 | - | - | Stock Option (Right to Buy) | |
| Chirfi Guindo | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 34,578 | 34,578 | - | - | Stock Option (Right to Buy) | |
| Jennifer Zachary | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 41,494 | 41,494 | - | - | Stock Option (Right to Buy) | |
| Caroline Litchfield | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 58,783 | 58,783 | - | - | Stock Option (Right to Buy) | |
| David Michael Williams | EVP,Chief Info&Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 19,364 | 19,364 | - | - | Stock Option (Right to Buy) | |
| Dean Y. Li | Executive VP & President, MRL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 77,455 | 77,455 | - | - | Stock Option (Right to Buy) | |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 9,682 | 9,682 | - | - | Stock Option (Right to Buy) | |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 1,781 | 1,781 | - | - | Restricted Stock Unit | |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 20,747 | 20,747 | - | - | Stock Option (Right to Buy) | |
| Cristal N. Downing | Chief Comm. & Public Afrs Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 17,981 | 17,981 | - | - | Stock Option (Right to Buy) | |
| Jannie Oosthuizen | President, U.S. Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 20,747 | 20,747 | - | - | Stock Option (Right to Buy) | |
| Joseph Romanelli | President, Human Health Int?l | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 6,786 | 6,786 | - | - | Restricted Stock Unit | |
| Joseph Romanelli | President, Human Health Int?l | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 23,513 | 23,513 | - | - | Stock Option (Right to Buy) | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 930 | 0 | - | - | Restricted Stock Unit | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 115.47 per share. | 01 May 2023 | 930 | 44,878 (0%) | 0% | 115.5 | 107,387 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.47 per share. | 01 May 2023 | 319 | 44,559 (0%) | 0% | 115.5 | 36,835 | Common Stock |
| Caroline Litchfield | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.47 per share. | 01 May 2023 | 427 | 31,691 (0%) | 0% | 115.5 | 49,306 | Common Stock |
| Caroline Litchfield | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 866 | 0 | - | - | Restricted Stock Unit | |
| Caroline Litchfield | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 115.47 per share. | 01 May 2023 | 866 | 32,118 (0%) | 0% | 115.5 | 99,997 | Common Stock |
| David Michael Williams | EVP,Chief Info&Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 115.47 per share. | 01 May 2023 | 577 | 12,730 (0%) | 0% | 115.5 | 66,626 | Common Stock |
| David Michael Williams | EVP,Chief Info&Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 6,035 | 0 | - | - | Stock Option (Right to Buy) | |
| David Michael Williams | EVP,Chief Info&Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 577 | 0 | - | - | Restricted Stock Unit | |
| David Michael Williams | EVP,Chief Info&Digital Officer | Sale of securities on an exchange or to another person at price $ 116.82 per share. | 01 May 2023 | 7,509 | 11,058 (0%) | 0% | 116.8 | 877,222 | Common Stock |
| David Michael Williams | EVP,Chief Info&Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.04 per share. | 01 May 2023 | 6,035 | 18,567 (0%) | 0% | 56.0 | 338,201 | Common Stock |
| David Michael Williams | EVP,Chief Info&Digital Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.47 per share. | 01 May 2023 | 198 | 12,532 (0%) | 0% | 115.5 | 22,863 | Common Stock |
| Dean Y. Li | Executive VP & President, MRL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.47 per share. | 01 May 2023 | 524 | 20,471 (0%) | 0% | 115.5 | 60,506 | Common Stock |
| Dean Y. Li | Executive VP & President, MRL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 115.47 per share. | 01 May 2023 | 1,062 | 20,995 (0%) | 0% | 115.5 | 122,629 | Common Stock |
| Dean Y. Li | Executive VP & President, MRL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 1,062 | 0 | - | - | Restricted Stock Unit | |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.47 per share. | 01 May 2023 | 221 | 4,154 (0%) | 0% | 115.5 | 25,519 | Common Stock |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 115.47 per share. | 01 May 2023 | 643 | 4,375 (0%) | 0% | 115.5 | 74,247 | Common Stock |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 643 | 0 | - | - | Restricted Stock Unit | |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 866 | 0 | - | - | Restricted Stock Unit | |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.47 per share. | 01 May 2023 | 427 | 18,591 (0%) | 0% | 115.5 | 49,306 | Common Stock |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 115.47 per share. | 01 May 2023 | 866 | 18,901 (0%) | 0% | 115.5 | 99,997 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.47 per share. | 01 May 2023 | 427 | 19,299 (0%) | 0% | 115.5 | 49,306 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 866 | 0 | - | - | Restricted Stock Unit | |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 115.47 per share. | 01 May 2023 | 866 | 19,726 (0%) | 0% | 115.5 | 99,997 | Common Stock |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 66,163 | 0 | - | - | Stock Option (Right to Buy) | |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.04 per share. | 28 Apr 2023 | 75,436 | 229,928 (0%) | 0% | 56.0 | 4,227,433 | Common Stock |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.07 per share. | 28 Apr 2023 | 66,163 | 220,655 (0%) | 0% | 62.1 | 4,106,737 | Common Stock |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 75,436 | 0 | - | - | Stock Option (Right to Buy) | |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Sale of securities on an exchange or to another person at price $ 116.03 per share. | 28 Apr 2023 | 75,436 | 154,492 (0%) | 0% | 116.0 | 8,752,749 | Common Stock |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Sale of securities on an exchange or to another person at price $ 115.00 per share. | 28 Apr 2023 | 66,163 | 154,492 (0%) | 0% | 115.0 | 7,608,844 | Common Stock |
| Robert M. Davis | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.04 per share. | 28 Apr 2023 | 143,329 | 415,145 (0%) | 0% | 56.0 | 8,032,157 | Common Stock |
| Robert M. Davis | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 114.93 per share. | 28 Apr 2023 | 143,329 | 271,816 (0%) | 0% | 114.9 | 16,472,845 | Common Stock |
| Robert M. Davis | Director, Chairman, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 143,329 | 0 | - | - | Stock Option (Right to Buy) | |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 115.07 per share. | 13 Apr 2023 | 67,892 | 0 (0%) | 0% | 115.1 | 7,812,366 | Common Stock |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2023 | 66,163 | 0 | - | - | Stock Option (Right to Buy) | |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2023 | 67,892 | 0 | - | - | Stock Option (Right to Buy) | |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 115.06 per share. | 13 Apr 2023 | 66,163 | 67,892 (0%) | 0% | 115.1 | 7,612,702 | Common Stock |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.07 per share. | 13 Apr 2023 | 66,163 | 134,055 (0%) | 0% | 62.1 | 4,106,737 | Common Stock |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.04 per share. | 13 Apr 2023 | 67,892 | 67,892 (0%) | 0% | 56.0 | 3,804,668 | Common Stock |
| Peter C. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 281 | 118,477 | - | - | Phantom Stock | |
| Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 422 | 87,408 | - | - | Phantom Stock | |
| Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 304 | 17,499 | - | - | Phantom Stock | |
| Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 76 | 10,339 | - | - | Phantom Stock | |
| Joseph Romanelli | President, Human Health Int?l | Sale of securities on an exchange or to another person at price $ 108.22 per share. | 15 Feb 2023 | 5,000 | 20,284 (0%) | 0% | 108.2 | 541,101 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 109.10 per share. | 13 Feb 2023 | 1,815 | 33,085 (0%) | 0% | 109.1 | 198,017 | Common Stock |
| David Michael Williams | EVP,Chief Info&Digital Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.72 per share. | 10 Feb 2023 | 413 | 12,091 (0%) | 0% | 106.7 | 44,075 | Common Stock |
| David Michael Williams | EVP,Chief Info&Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 1,205 | 0 | - | - | Restricted Stock Unit | |
| David Michael Williams | EVP,Chief Info&Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 106.72 per share. | 10 Feb 2023 | 1,205 | 12,504 (0%) | 0% | 106.7 | 128,598 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 107.00 per share. | 09 Feb 2023 | 5,000 | 34,900 (0%) | 0% | 107.0 | 535,007 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 104.25 per share. | 06 Feb 2023 | 4,436 | 39,900 (0%) | 0% | 104.3 | 462,473 | Common Stock |
| Jennifer Zachary | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 103.17 per share. | 03 Feb 2023 | 75,436 | 53,919 (0%) | 0% | 103.2 | 7,782,762 | Common Stock |
| Jennifer Zachary | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 75,436 | 0 | - | - | Stock Option (Right to Buy) | |
| Jennifer Zachary | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.04 per share. | 03 Feb 2023 | 75,436 | 129,355 (0%) | 0% | 56.0 | 4,227,433 | Common Stock |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 15,628 | 153,500 (0%) | 0% | 109.9 | 1,717,205 | Common Stock |
| Robert M. Davis | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 24,224 | 271,816 (0%) | 0% | 109.9 | 2,661,733 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 12,192 | 44,336 (0%) | 0% | 109.9 | 1,339,657 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 2,846 | 43,948 (0%) | 0% | 109.9 | 312,718 | Common Stock |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 17,495 | 46,995 (0%) | 0% | 109.9 | 1,922,351 | Common Stock |
| Jennifer Zachary | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 15,631 | 53,919 (0%) | 0% | 109.9 | 1,717,534 | Common Stock |
| Caroline Litchfield | EVP & CFO | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 2,656 | 30,186 (0%) | 0% | 109.9 | 291,841 | Common Stock |
| David Michael Williams | EVP,Chief Info&Digital Officer | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 1,745 | 11,007 (0%) | 0% | 109.9 | 191,741 | Common Stock |
| Dean Y. Li | Executive VP & President, MRL | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 3,275 | 19,933 (0%) | 0% | 109.9 | 359,857 | Common Stock |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 2,651 | 17,989 (0%) | 0% | 109.9 | 291,292 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 2,091 | 18,821 (0%) | 0% | 109.9 | 229,759 | Common Stock |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 111.73 per share. | 09 Jan 2023 | 4,538 | 73,358 (0%) | 0% | 111.7 | 507,048 | Common Stock |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 83,994 | 0 | - | - | Stock Option (Right to Buy) | |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 110.61 per share. | 09 Jan 2023 | 35,598 | 77,896 (0%) | 0% | 110.6 | 3,937,659 | Common Stock |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 113.78 per share. | 09 Jan 2023 | 38,216 | 31,202 (0%) | 0% | 113.8 | 4,348,033 | Common Stock |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.06 per share. | 09 Jan 2023 | 83,994 | 113,494 (0%) | 0% | 53.1 | 4,456,722 | Common Stock |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 112.78 per share. | 09 Jan 2023 | 3,940 | 69,418 (0%) | 0% | 112.8 | 444,362 | Common Stock |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 114.46 per share. | 09 Jan 2023 | 1,702 | 29,500 (0%) | 0% | 114.5 | 194,813 | Common Stock |
| Peter C. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 270 | 117,421 | - | - | Phantom Stock | |
| Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 405 | 86,420 | - | - | Phantom Stock | |
| Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 292 | 17,083 | - | - | Phantom Stock | |
| Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 73 | 10,192 | - | - | Phantom Stock | |
| Robert M. Davis | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 103.59 per share. | 09 Nov 2022 | 100 | 247,592 (0%) | 0% | 103.6 | 10,359 | Common Stock |
| Robert M. Davis | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 102.98 per share. | 09 Nov 2022 | 79,918 | 247,692 (0%) | 0% | 103.0 | 8,229,924 | Common Stock |
| Robert M. Davis | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 101.94 per share. | 09 Nov 2022 | 87,595 | 327,610 (0%) | 0% | 101.9 | 8,929,557 | Common Stock |
| Robert M. Davis | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2022 | 167,613 | 415,205 (0%) | 0% | 0 | Common Stock | |
| Robert M. Davis | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2022 | 167,613 | 0 | - | - | Stock Option (Right to Buy) | |
| Jannie Oosthuizen | President, U.S. Market | Sale of securities on an exchange or to another person at price $ 103.21 per share. | 09 Nov 2022 | 1,795 | 16,730 (0%) | 0% | 103.2 | 185,262 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 101.00 per share. | 08 Nov 2022 | 20,000 | 32,144 (0%) | 0% | 101 | 2,020,000 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 15,000 | 824 | - | - | Stock Option (Right to Buy) | |
| Steven C. Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 20,000 | 15,824 | - | - | Stock Option (Right to Buy) | |
| Steven C. Mizell | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 101.42 per share. | 08 Nov 2022 | 15,000 | 32,144 (0%) | 0% | 101.4 | 1,521,278 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 15,000 | 47,144 (0%) | 0% | 0 | Common Stock | |
| Steven C. Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 20,000 | 52,144 (0%) | 0% | 0 | Common Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 98.45 per share. | 07 Nov 2022 | 24,914 | 911,508 (0%) | 0% | 98.5 | 2,452,880 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 235,769 | 0 | - | - | Stock Option (Right to Buy) | |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 100.07 per share. | 07 Nov 2022 | 84,721 | 700,653 (0%) | 0% | 100.1 | 8,477,717 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 99.42 per share. | 07 Nov 2022 | 126,134 | 785,374 (0%) | 0% | 99.4 | 12,540,835 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 235,769 | 936,422 (0%) | 0% | 0 | Common Stock | |
| Jannie Oosthuizen | President, U.S. Market | Sale of securities on an exchange or to another person at price $ 99.47 per share. | 07 Nov 2022 | 45,561 | 18,525 (0%) | 0% | 99.5 | 4,531,980 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 13,540 | 57,041 (0%) | 0% | 0 | Common Stock | |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 17,455 | 43,501 (0%) | 0% | 0 | Common Stock | |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 14,703 | 0 | - | - | Stock Option (Right to Buy) | |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 17,455 | 0 | - | - | Stock Option (Right to Buy) | |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 14,703 | 26,046 (0%) | 0% | 0 | Common Stock | |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 13,540 | 6,773 | - | - | Stock Option (Right to Buy) | |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 7,045 | 14,094 | - | - | Stock Option (Right to Buy) | |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 7,045 | 64,086 (0%) | 0% | 0 | Common Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 99.08 per share. | 03 Nov 2022 | 34,810 | 700,653 (0%) | 0% | 99.1 | 3,448,989 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2022 | 235,000 | 235,769 | - | - | Stock Option (Right to Buy) | |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2022 | 235,000 | 470,769 | - | - | Stock Option (Right to Buy) | |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 98.53 per share. | 03 Nov 2022 | 200,190 | 735,463 (0%) | 0% | 98.5 | 19,725,241 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2022 | 235,000 | 935,653 (0%) | 0% | 0 | Common Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 99.09 per share. | 03 Nov 2022 | 20,383 | 700,653 (0%) | 0% | 99.1 | 2,019,804 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 98.68 per share. | 03 Nov 2022 | 214,617 | 721,036 (0%) | 0% | 98.7 | 21,178,084 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2022 | 235,000 | 935,653 (0%) | 0% | 0 | Common Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 300,000 | 1,006,283 (0%) | 0% | 0 | Common Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 134,172 | 705,769 | - | - | Stock Option (Right to Buy) | |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 165,828 | 0 | - | - | Stock Option (Right to Buy) | |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 300,000 | 165,828 | - | - | Stock Option (Right to Buy) | |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 100.40 per share. | 01 Nov 2022 | 94,339 | 700,653 (0%) | 0% | 100.4 | 9,471,739 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 99.68 per share. | 01 Nov 2022 | 205,661 | 794,992 (0%) | 0% | 99.7 | 20,500,103 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 134,172 | 1,000,653 (0%) | 0% | 0 | Common Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 165,828 | 866,481 (0%) | 0% | 0 | Common Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Nov 2022 | 1,470 | 700,653 (0%) | 0% | 0 | Common Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Nov 2022 | 2,450 | 702,123 (0%) | 0% | 0 | Common Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Nov 2022 | 1,710 | 704,573 (0%) | 0% | 0 | Common Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 101.05 per share. | 01 Nov 2022 | 700 | 706,283 (0%) | 0% | 101.0 | 70,733 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 100.22 per share. | 01 Nov 2022 | 96,981 | 706,983 (0%) | 0% | 100.2 | 9,719,843 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 99.61 per share. | 01 Nov 2022 | 202,319 | 803,964 (0%) | 0% | 99.6 | 20,152,287 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 300,000 | 465,828 | - | - | Stock Option (Right to Buy) | |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 567,084 | 1,273,367 (0%) | 0% | 0 | Common Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 99.15 per share. | 28 Oct 2022 | 75,489 | 1,197,878 (0%) | 0% | 99.2 | 7,484,855 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 100.25 per share. | 28 Oct 2022 | 313,232 | 884,646 (0%) | 0% | 100.3 | 31,402,730 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 100.80 per share. | 28 Oct 2022 | 178,363 | 706,283 (0%) | 0% | 100.8 | 17,978,687 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 300,000 | 1,006,283 (0%) | 0% | 0 | Common Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 99.82 per share. | 28 Oct 2022 | 70,698 | 935,585 (0%) | 0% | 99.8 | 7,056,770 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 101.03 per share. | 28 Oct 2022 | 229,302 | 706,283 (0%) | 0% | 101.0 | 23,167,321 | Common Stock |
| Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 567,084 | 0 | - | - | Stock Option (Right to Buy) | |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 59,564 | 196,541 (0%) | 0% | 0 | Common Stock | |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 104,993 | 0 | - | - | Stock Option (Right to Buy) | |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 59,564 | 0 | - | - | Stock Option (Right to Buy) | |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Sale of securities on an exchange or to another person at price $ 100.26 per share. | 28 Oct 2022 | 164,557 | 136,977 (0%) | 0% | 100.3 | 16,499,094 | Common Stock |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 104,993 | 301,534 (0%) | 0% | 0 | Common Stock | |
| Steven C. Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 17,000 | 57,144 (0%) | 0% | 0 | Common Stock | |
| Steven C. Mizell | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 28 Oct 2022 | 17,000 | 40,144 (0%) | 0% | 100 | 1,700,000 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 98.84 per share. | 28 Oct 2022 | 8,000 | 32,144 (0%) | 0% | 98.8 | 790,720 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 17,000 | 35,824 | - | - | Stock Option (Right to Buy) | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 15,000 | 15,875 | - | - | Stock Option (Right to Buy) | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 16,997 | 0 | - | - | Stock Option (Right to Buy) | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Sale of securities on an exchange or to another person at price $ 100.34 per share. | 28 Oct 2022 | 31,997 | 41,102 (0%) | 0% | 100.3 | 3,210,685 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 15,000 | 73,099 (0%) | 0% | 0 | Common Stock | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 16,997 | 58,099 (0%) | 0% | 0 | Common Stock | |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 51,055 | 0 | - | - | Stock Option (Right to Buy) | |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 15,213 | 60,821 (0%) | 0% | 0 | Common Stock | |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 34,024 | 94,845 (0%) | 0% | 0 | Common Stock | |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 51,055 | 145,900 (0%) | 0% | 0 | Common Stock | |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 100.10 per share. | 28 Oct 2022 | 100,292 | 45,608 (0%) | 0% | 100.1 | 10,039,380 | Common Stock |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 15,213 | 0 | - | - | Stock Option (Right to Buy) | |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 34,024 | 0 | - | - | Stock Option (Right to Buy) | |
| Jennifer Zachary | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 68,367 | 123,015 (0%) | 0% | 0 | Common Stock | |
| Jennifer Zachary | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 99.85 per share. | 28 Oct 2022 | 65,487 | 38,040 (0%) | 0% | 99.9 | 6,538,877 | Common Stock |
| Jennifer Zachary | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 99.07 per share. | 28 Oct 2022 | 99,768 | 103,527 (0%) | 0% | 99.1 | 9,884,016 | Common Stock |
| Jennifer Zachary | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 28,396 | 203,295 (0%) | 0% | 0 | Common Stock | |
| Jennifer Zachary | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 51,884 | 174,899 (0%) | 0% | 0 | Common Stock | |
| Jennifer Zachary | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 28,396 | 56,792 | - | - | Stock Option (Right to Buy) | |
| Jennifer Zachary | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 51,884 | 25,946 | - | - | Stock Option (Right to Buy) | |
| Jennifer Zachary | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 68,367 | 0 | - | - | Stock Option (Right to Buy) | |
| Jannie Oosthuizen | President, U.S. Market | Sale of securities on an exchange or to another person at price $ 100.21 per share. | 28 Oct 2022 | 3,633 | 10,880 (0%) | 0% | 100.2 | 364,065 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 100.77 per share. | 28 Oct 2022 | 913 | 11,793 (0%) | 0% | 100.8 | 92,003 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.77 per share. | 28 Oct 2022 | 450 | 11,343 (0%) | 0% | 100.8 | 45,347 | Common Stock |
| Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 913 | 915 | - | - | Restricted Stock Unit | |
| Peter C. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 348 | 116,237 | - | - | Phantom Stock | |
| Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 522 | 85,350 | - | - | Phantom Stock | |
| Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 377 | 16,662 | - | - | Phantom Stock | |
| Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 94 | 10,039 | - | - | Phantom Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 28,532 | 28,532 | - | - | Restricted Stock Unit | |
| David Michael Williams | EVP,Chief Info&Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 17,119 | 17,119 | - | - | Restricted Stock Unit | |
| Peter C. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 329 | 115,036 | - | - | Phantom Stock | |
| Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 493 | 84,209 | - | - | Phantom Stock | |
| Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 356 | 16,167 | - | - | Phantom Stock | |
| Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 89 | 9,871 | - | - | Phantom Stock | |
| Douglas M. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 2,363 | - | - | Phantom Stock | |
| Inge G. Thulin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 16,518 | - | - | Phantom Stock | |
| Patricia F. Russo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 47,506 | - | - | Phantom Stock | |
| Peter C. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 114,707 | - | - | Phantom Stock | |
| Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 83,715 | - | - | Phantom Stock | |
| Pamela J. Craig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 23,152 | - | - | Phantom Stock | |
| Risa J. Lavizzo-Mourey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 7,892 | - | - | Phantom Stock | |
| Kathy J. Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 8,018 | - | - | Phantom Stock | |
| Paul B. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 23,152 | - | - | Phantom Stock | |
| Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 15,811 | - | - | Phantom Stock | |
| Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 9,782 | - | - | Phantom Stock | |
| Stephen L. Mayo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 5,297 | - | - | Phantom Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 28,703 | 28,703 | - | - | Restricted Stock Unit | |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 58,252 | 58,252 | - | - | Stock Option (Right to Buy) | |
| Robert M. Davis | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 228,155 | 228,155 | - | - | Stock Option (Right to Buy) | |
| Steven C. Mizell | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 40,777 | 40,777 | - | - | Stock Option (Right to Buy) | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 902 | 0 | - | - | Restricted Stock Unit | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 13,592 | 13,592 | - | - | Stock Option (Right to Buy) | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.65 per share. | 03 May 2022 | 902 | 40,788 (0%) | 0% | 87.6 | 79,060 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.65 per share. | 03 May 2022 | 309 | 40,479 (0%) | 0% | 87.7 | 27,084 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.10 per share. | 03 May 2022 | 949 | 41,428 (0%) | 0% | 87.1 | 82,658 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 949 | 1,900 | - | - | Restricted Stock Unit | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,411 | 2,411 | - | - | Restricted Stock Unit | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.10 per share. | 03 May 2022 | 326 | 41,102 (0%) | 0% | 87.1 | 28,395 | Common Stock |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 58,252 | 58,252 | - | - | Stock Option (Right to Buy) | |
| Jennifer Zachary | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 58,252 | 58,252 | - | - | Stock Option (Right to Buy) | |
| Caroline Litchfield | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 53,398 | 53,398 | - | - | Stock Option (Right to Buy) | |
| Caroline Litchfield | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.65 per share. | 03 May 2022 | 773 | 27,799 (0%) | 0% | 87.6 | 67,753 | Common Stock |
| Caroline Litchfield | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.65 per share. | 03 May 2022 | 373 | 27,426 (0%) | 0% | 87.6 | 32,693 | Common Stock |
| Caroline Litchfield | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 773 | 0 | - | - | Restricted Stock Unit | |
| David Michael Williams | EVP,Chief Info&Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 427 | 0 | - | - | Restricted Stock Unit | |
| David Michael Williams | EVP,Chief Info&Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 21,359 | 21,359 | - | - | Stock Option (Right to Buy) | |
| David Michael Williams | EVP,Chief Info&Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.65 per share. | 03 May 2022 | 427 | 9,409 (0%) | 0% | 87.7 | 37,427 | Common Stock |
| David Michael Williams | EVP,Chief Info&Digital Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.65 per share. | 03 May 2022 | 147 | 9,262 (0%) | 0% | 87.7 | 12,885 | Common Stock |
| Dean Y. Li | Executive VP & President, MRL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 75,728 | 75,728 | - | - | Stock Option (Right to Buy) | |
| Dean Y. Li | Executive VP & President, MRL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 773 | 0 | - | - | Restricted Stock Unit | |
| Dean Y. Li | Executive VP & President, MRL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.65 per share. | 03 May 2022 | 381 | 16,457 (0%) | 0% | 87.7 | 33,395 | Common Stock |
| Dean Y. Li | Executive VP & President, MRL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.65 per share. | 03 May 2022 | 773 | 16,838 (0%) | 0% | 87.6 | 67,753 | Common Stock |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 452 | 0 | - | - | Restricted Stock Unit | |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.65 per share. | 03 May 2022 | 155 | 3,129 (0%) | 0% | 87.7 | 13,586 | Common Stock |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.65 per share. | 03 May 2022 | 452 | 3,284 (0%) | 0% | 87.7 | 39,618 | Common Stock |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 813 | 1,629 | - | - | Restricted Stock Unit | |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,067 | 2,067 | - | - | Restricted Stock Unit | |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.10 per share. | 03 May 2022 | 813 | 3,942 (0%) | 0% | 87.1 | 70,812 | Common Stock |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.10 per share. | 03 May 2022 | 279 | 3,663 (0%) | 0% | 87.1 | 24,301 | Common Stock |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 11,650 | 11,650 | - | - | Stock Option (Right to Buy) | |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.65 per share. | 03 May 2022 | 773 | 15,270 (0%) | 0% | 87.6 | 67,753 | Common Stock |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 773 | 0 | - | - | Restricted Stock Unit | |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 25,243 | 25,243 | - | - | Stock Option (Right to Buy) | |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.10 per share. | 03 May 2022 | 436 | 15,338 (0%) | 0% | 87.1 | 37,976 | Common Stock |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.10 per share. | 03 May 2022 | 885 | 15,774 (0%) | 0% | 87.1 | 77,084 | Common Stock |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.65 per share. | 03 May 2022 | 381 | 14,889 (0%) | 0% | 87.7 | 33,395 | Common Stock |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 885 | 1,772 | - | - | Restricted Stock Unit | |
| Cristal N. Downing | Chief Comm. & Public Afrs Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 19,417 | 19,417 | - | - | Stock Option (Right to Buy) | |
| Arpa Garay | SVP Human Health Global Mktg. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.65 per share. | 03 May 2022 | 221 | 1,461 (0%) | 0% | 87.7 | 19,371 | Common Stock |
| Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 907 | 1,819 | - | - | Restricted Stock Unit | |
| Arpa Garay | SVP Human Health Global Mktg. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.10 per share. | 03 May 2022 | 259 | 2,109 (0%) | 0% | 87.1 | 22,559 | Common Stock |
| Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.10 per share. | 03 May 2022 | 907 | 2,368 (0%) | 0% | 87.1 | 79,000 | Common Stock |
| Arpa Garay | SVP Human Health Global Mktg. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 21,359 | 21,359 | - | - | Stock Option (Right to Buy) | |
| Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 773 | 0 | - | - | Restricted Stock Unit | |
| Arpa Garay | SVP Human Health Global Mktg. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.65 per share. | 03 May 2022 | 221 | 1,461 (0%) | 0% | 87.7 | 19,371 | Common Stock |
| Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.65 per share. | 03 May 2022 | 773 | 1,682 (0%) | 0% | 87.6 | 67,753 | Common Stock |
| Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 773 | 0 | - | - | Restricted Stock Unit | |
| Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.65 per share. | 03 May 2022 | 773 | 1,682 (0%) | 0% | 87.6 | 67,753 | Common Stock |
| Jannie Oosthuizen | SVP, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 907 | 1,819 | - | - | Restricted Stock Unit | |
| Jannie Oosthuizen | SVP, U.S. Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 21,359 | 21,359 | - | - | Stock Option (Right to Buy) | |
| Jannie Oosthuizen | SVP, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.65 per share. | 03 May 2022 | 773 | 14,434 (0%) | 0% | 87.6 | 67,753 | Common Stock |
| Jannie Oosthuizen | SVP, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.65 per share. | 03 May 2022 | 381 | 14,053 (0%) | 0% | 87.7 | 33,395 | Common Stock |
| Jannie Oosthuizen | SVP, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 773 | 0 | - | - | Restricted Stock Unit | |
| Jannie Oosthuizen | SVP, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.10 per share. | 03 May 2022 | 907 | 14,960 (0%) | 0% | 87.1 | 79,000 | Common Stock |
| Jannie Oosthuizen | SVP, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.10 per share. | 03 May 2022 | 447 | 14,513 (0%) | 0% | 87.1 | 38,934 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 928 | 930 | - | - | Restricted Stock Unit | |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.69 per share. | 01 May 2022 | 928 | 40,204 (0%) | 0% | 88.7 | 82,304 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.69 per share. | 01 May 2022 | 318 | 39,886 (0%) | 0% | 88.7 | 28,203 | Common Stock |
| Caroline Litchfield | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.69 per share. | 01 May 2022 | 866 | 27,453 (0%) | 0% | 88.7 | 76,806 | Common Stock |
| Caroline Litchfield | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.69 per share. | 01 May 2022 | 427 | 27,026 (0%) | 0% | 88.7 | 37,871 | Common Stock |
| Caroline Litchfield | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 866 | 866 | - | - | Restricted Stock Unit | |
| David Michael Williams | EVP,Chief Info&Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 577 | 577 | - | - | Restricted Stock Unit | |
| David Michael Williams | EVP,Chief Info&Digital Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.69 per share. | 01 May 2022 | 577 | 9,180 (0%) | 0% | 88.7 | 51,174 | Common Stock |
| David Michael Williams | EVP,Chief Info&Digital Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.69 per share. | 01 May 2022 | 198 | 8,982 (0%) | 0% | 88.7 | 17,561 | Common Stock |
| Dean Y. Li | Executive VP & President, MRL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.69 per share. | 01 May 2022 | 523 | 16,065 (0%) | 0% | 88.7 | 46,385 | Common Stock |
| Dean Y. Li | Executive VP & President, MRL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 1,061 | 1,062 | - | - | Restricted Stock Unit | |
| Dean Y. Li | Executive VP & President, MRL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.69 per share. | 01 May 2022 | 1,061 | 16,588 (0%) | 0% | 88.7 | 94,100 | Common Stock |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.69 per share. | 01 May 2022 | 640 | 3,052 (0%) | 0% | 88.7 | 56,762 | Common Stock |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 640 | 643 | - | - | Restricted Stock Unit | |
| Lisa LeCointe-Cephas | SVP Chief Ethics & Com Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.69 per share. | 01 May 2022 | 220 | 2,832 (0%) | 0% | 88.7 | 19,512 | Common Stock |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 866 | 866 | - | - | Restricted Stock Unit | |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.69 per share. | 01 May 2022 | 427 | 14,497 (0%) | 0% | 88.7 | 37,871 | Common Stock |
| Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.69 per share. | 01 May 2022 | 866 | 14,924 (0%) | 0% | 88.7 | 76,806 | Common Stock |
| Arpa Garay | SVP Human Health Global Mktg. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.69 per share. | 01 May 2022 | 247 | 909 (0%) | 0% | 88.7 | 21,906 | Common Stock |
| Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 866 | 866 | - | - | Restricted Stock Unit | |
| Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.69 per share. | 01 May 2022 | 866 | 1,156 (0%) | 0% | 88.7 | 76,806 | Common Stock |
| Jannie Oosthuizen | SVP, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.69 per share. | 01 May 2022 | 866 | 14,088 (0%) | 0% | 88.7 | 76,806 | Common Stock |
| Jannie Oosthuizen | SVP, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 866 | 866 | - | - | Restricted Stock Unit | |
| Jannie Oosthuizen | SVP, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.69 per share. | 01 May 2022 | 427 | 13,661 (0%) | 0% | 88.7 | 37,871 | Common Stock |
| Peter C. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 365 | 111,460 | - | - | Phantom Stock | |
| Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 137 | 80,714 | - | - | Phantom Stock | |
| Mary Ellen Coe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 396 | 13,344 | - | - | Phantom Stock | |
| Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 198 | 7,362 | - | - | Phantom Stock | |
| Kenneth C. Frazier | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 73.51 per share. | 24 Feb 2022 | 119,488 | 706,283 (0%) | 0% | 73.5 | 8,783,563 | Common Stock |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Grant, award, or other acquisition of securities at price $ 73.51 per share. | 24 Feb 2022 | 15,966 | 133,896 (0%) | 0% | 73.5 | 1,173,661 | Common Stock |
| Robert M. Davis | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 73.51 per share. | 24 Feb 2022 | 29,896 | 247,592 (0%) | 0% | 73.5 | 2,197,655 | Common Stock |
| Steven C. Mizell | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 73.51 per share. | 24 Feb 2022 | 14,571 | 40,144 (0%) | 0% | 73.5 | 1,071,114 | Common Stock |
| Rita A. Karachun | Sr. VP Fince-Global Controller | Grant, award, or other acquisition of securities at price $ 73.51 per share. | 24 Feb 2022 | 3,478 | 39,276 (0%) | 0% | 73.5 | 255,668 | Common Stock |
| Julie L. Gerberding | EVP, Chief Patient Officer | Grant, award, or other acquisition of securities at price $ 73.51 per share. | 24 Feb 2022 | 9,550 | 48,712 (0%) | 0% | 73.5 | 702,021 | Common Stock |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 73.51 per share. | 24 Feb 2022 | 19,836 | 112,981 (0%) | 0% | 73.5 | 1,458,144 | Common Stock |
| Jennifer Zachary | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 73.51 per share. | 24 Feb 2022 | 18,420 | 53,419 (0%) | 0% | 73.5 | 1,354,054 | Common Stock |